When Will Trulicity's Main Patents Expire?
The primary patents protecting Trulicity (dulaglutide) are set to expire in the coming years. U.S. Patent No. 8,759,300, which covers certain formulations of dulaglutide, is listed to expire on May 20, 2027. [1] DrugPatentWatch.com indicates that other patents related to Trulicity also have expiration dates in the mid-2030s, such as U.S. Patent No. 10,815,292, expiring in October 2034. [2]
What Happens When Trulicity's Patents Expire?
Patent expiration opens the door for the development and approval of generic versions of Trulicity. Once Trulicity's exclusivity periods conclude, manufacturers can submit applications to regulatory bodies like the U.S. Food and Drug Administration (FDA) for approval of their biosimilar or generic equivalents. [3] The availability of generics typically leads to increased competition and can result in lower drug prices for patients and healthcare systems.
Can Generic Trulicity Enter the Market Before Patent Expiry?
The entry of generic Trulicity before the listed patent expiration dates would likely depend on the outcome of any patent litigation. Companies often challenge existing patents to gain earlier market access for their generic products. [4] If such challenges are successful, generic versions could become available sooner than anticipated.
What Are the Key Trulicity Patents and Their Durations?
Several patents are associated with Trulicity, covering different aspects of the drug, including its formulation, method of use, and manufacturing. As noted, U.S. Patent No. 8,759,300 expires in May 2027, and U.S. Patent No. 10,815,292 expires in October 2034. [1][2] The specific expiration dates can impact the timeline for generic competition.
Who are the Major Players in the Trulicity Market?
Eli Lilly and Company is the manufacturer of Trulicity. [5] Following patent expiration, other pharmaceutical companies that successfully develop and receive approval for generic versions of dulaglutide will become competitors.
What is the Clinical Significance of Dulaglutide?
Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycemic control in adults with type 2 diabetes. [5] It also has demonstrated cardiovascular benefits, reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease or multiple cardiovascular risk factors. [5]
What is the Expected Impact on Trulicity Pricing?
The introduction of generic dulaglutide is expected to lead to a significant decrease in the price of the medication. This is a common trend observed in the pharmaceutical market once patent protections expire and multiple manufacturers enter the market with lower-cost alternatives.
Sources:
[1] https://drugpatentwatch.com/
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/drugs/abbreviated-new-drug-applications-andnas/understanding-generics-drug-facts
[4] https://www.drugpatentwatch.com/about-us
[5] https://www.lilly.com/